LOADING
Tag: Adolescents
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – BioSpace
September 19, 2025
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
chat_bubble0 Comment
visibility80 Views
Phase 3: Delgocitinib improves chronic hand eczema in adolescents – Contemporary Pediatrics
February 5, 2025
Phase 3: Delgocitinib improves chronic hand eczema in adolescents Contemporary Pediatrics Source link
chat_bubble0 Comment
visibility157 Views
FDA Expands Label for Abrocitinib to Include Adolescents With … – MD Magazine
February 10, 2023
FDA Expands Label for Abrocitinib to Include Adolescents With … MD Magazine Source link
chat_bubble0 Comment
visibility268 Views
Dupilumab Promising Long Term for Atopic Dermatitis in Adolescents
July 11, 2022
Dupilumab had an acceptable long-term safety and efficacy for adolescents with moderate to severe atopic dermatitis (AD), according to data from an open-label extension (OLE) phase 3 trial published in the American Journal of Clinical Dermatology. For adolescents (aged 12 to 18 years) with moderate to severe AD enrolled in the LIBERTY AD PED-OLE study, […]
chat_bubble0 Comment
visibility376 Views